pharmagapI don't know if this will go lower. It may. It depends how many are looking for a tax loss. Right now there isn't much news and that means there aren't buyers. It would be nice if the management would provide an update on progress. Have they chosen a cancer target? Are they testing at another facility on Bladder Cancer? Queens? Have they selected a drug delivery mechanism? Where are the results from OHRI and Sloan Kettering? I thought they were going to build market awareness so that the share price would reflect the growing underlying value of the company. Thats what it says on their August slide show. It doesn't appear to be working.